Alex Keown

By Alex Keown | May 6, 2024 BioBuzz has been building life science communities for 14 years because we believe in the power of personal networks to unlock your career potential.

Integral Molecular announced the spin-out of a new sister company, Cell Surface Bio, that is poised to deliver antibodies that always work. The company's VeRSaMAb research antibodies are validated for assays that include flow cytometry and immunofluorescence, are recombinantly produced, and specific as tested using cross-reactivity assessment against 6,000 cell surface proteins

With nimbleness and innovation, the hyper-virtual business model can be highly attractive to venture capitalists. In a recent three-part series called “Going Virtual” Launch Bio and Kymanox outlined the many benefits of this model for life science startups, including speed to market, de-risking growth and creating stability.

By Alex Keown | May 30, 2024 BioBuzz has been building life science communities for 14 years because we believe in the power of personal networks to unlock your career potential.

Companies committed to making high-speed internet available to all From work to play to school, the world is connected via the internet.

By Alex Keown | August 23, 2024 BioBuzz has been connecting the life science workforce since 2009.

While this year's tax season should end without too many surprises, tax preparers say companies should already be thinking about 2025.

Innovation I95 BUSINESS By Alex Keown Oct 09, 2024 By Alex Keown

Ryan Polakoff is poised to run the logistics company after his father's retirement. I95 BUSINESS By Alex Keown Dec 05, 2024

Recent graduates find smaller firms better for work-life balance After working two years at a Big Four accounting firm in Chicago, a smaller firm was the perfect choice for Jen Sheehan.